Two Sigma Advisers »

Aardvark Therapeutics shares owned by Two Sigma Advisers

Quarter-by-quarter ownership of Aardvark Therapeutics (AARD) shares owned by Two Sigma Advisers from 13F filings

Historical chart of Two Sigma Advisers investment in Aardvark Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aardvark Therapeutics held by Two Sigma Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aardvark Therapeutics by Two Sigma Advisers

Quarter filed Position value Share count Share price at filing
2025-09-30 $342k 26k 13.29

More positions owned by Two Sigma Advisers

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Amazon (AMZN)
JPMorgan Chase & Co. (JPM)
Palantir Technologies Cl A (PLTR)
Netflix (NFLX)
Meta Platforms Cl A (META)
Bank of America Corporation (BAC)
Mastercard Incorporated Cl A (MA)
Costco Wholesale Corporation (COST)
Lockheed Martin Corporation (LMT)
Intuitive Surgical Com New (ISRG)
Adobe Systems Incorporated (ADBE)
Charles Schwab Corporation (SCHW)

View all positions for Two Sigma Advisers

Top funds holding Aardvark Therapeutics

Decheng Capital
Citadel Advisors
Laurion Capital Management
Vanguard Group
Adage Capital Partners GP
Millennium Management
BlackRock
Silverarc Capital Management
Schonfeld Strategic Advisors
Geode Capital Management
Cresset Asset Management
Cantor Fitzgerald, L. P.
State Street Corporation
Two Sigma Investments
Northern Trust

View all funds holding Aardvark Therapeutics